Patents by Inventor Eugene E. Galantay

Eugene E. Galantay has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 1-Alkyl, 1-phenyl-butenes
    Patent number: 4335124
    Abstract: The compounds are 4-phenyl-4-lower alkyl-substituted-3-buten-2-ones, and -2-halo-1,3-butadienes, e.g., 2-(p-biphenylyl)-2-penten-4-one, and are useful as pharmaceuticals.
    Type: Grant
    Filed: October 14, 1980
    Date of Patent: June 15, 1982
    Assignee: Sandoz, Inc.
    Inventor: Eugene E. Galantay
  • 1-Alkyl,1-phenyl-butenes
    Patent number: 4273787
    Abstract: The compounds are 4-phenyl-4-lower alkyl-substituted-3-buten-2-ones, and -2-halo-1,3-butadienes, e.g., 2-(p-biphenylyl)-2-penten-4-one, and are useful as pharmaceuticals.
    Type: Grant
    Filed: August 9, 1979
    Date of Patent: June 16, 1981
    Assignee: Sandoz, Inc.
    Inventor: Eugene E. Galantay
  • 1-Phenyl-2,3-butadien-1-ols and method of use
    Patent number: 4127658
    Abstract: Disclosed are compounds of the class 1-phenyl-2,3-butadien-1-ol e.g. 2-(p-biphenylyl)-3,4-pentadien-2-ol, which are useful by reason of their pharmacological activity in animals, e.g., as anti-inflammatory agents and tranquilizers. Said compounds can be prepared, e.g., by reduction of a corresponding 4-substituted-1-phenyl-2-butyne-1-ol with a complex hydride such as lithium aluminum hydride.
    Type: Grant
    Filed: March 23, 1978
    Date of Patent: November 28, 1978
    Assignee: Sandoz, Inc.
    Inventor: Eugene E. Galantay
  • P-(substituted and unsubstituted-phenyl)-1-phenyl-2,3-butadien-1-ols as pharmaceutical agents
    Patent number: 4100300
    Abstract: Disclosed are compounds of the class 1-phenyl-2,3-butadien-1-ol e.g. 2-(p-biphenyl)-3,4-pentadien-2-ol, which are useful by reason of their pharmacological activity in animals, e.g., as anti-inflammatory agents and tranquilizers. Said compounds can be prepared, e.g., by reduction of a corresponding 4-substituted-1-phenyl-2-butyne-1-ol with a complex hydride such as lithium aluminum hydride.
    Type: Grant
    Filed: February 17, 1977
    Date of Patent: July 11, 1978
    Assignee: Sandoz, Inc.
    Inventor: Eugene E. Galantay
  • Hypolipidemic allene carboxylic esters
    Patent number: 4073936
    Abstract: The compounds are 4-aryl substituted buta-2,3-dienoic acids and esters thereof which may also be lower alkyl-substituted at any of the 2- and 4- positions, e.g., 4-(p-methoxyphenyl)-2-methyl-buta-2,3-dienoic acid. The compounds are useful as pharmaceuticals, e.g., as antiinflammatory agents and hypolipidemic agents.
    Type: Grant
    Filed: November 17, 1976
    Date of Patent: February 14, 1978
    Assignee: Sandoz, Inc.
    Inventors: Eugene E. Galantay, Faizulla G. Kathawala
  • Anti-inflammatory 1-phenyl-2,3-butadien-1-ols, methods of use and compositions containing same
    Patent number: 4032580
    Abstract: Disclosed are compounds of the class 1-phenyl-2,3-butadien-1-ol e.g. 2-(p-biphenyl)-3,4-pentadien-2-ol, which are useful by reason of their pharmacological activity in animals, e.g., as anti-inflammatory agents and tranquilizers. Said compounds can be prepared, e.g., by reduction of a corresponding 4-substituted-1-phenyl-2-butyne-1-ol with a complex hydride such as lithium aluminum hydride.
    Type: Grant
    Filed: September 18, 1975
    Date of Patent: June 28, 1977
    Assignee: Sandoz, Inc.
    Inventor: Eugene E. Galantay
  • Hypolipidemic allene carboxylic acids
    Patent number: 4011339
    Abstract: The compounds are 4-aryl substituted buta-2,3-dienoic acids and esters thereof which may also be lower alkyl-substituted at any of the 2- and 4-positions, e.g., 4-(p-methoxyphenyl)-2-methyl-buta-2,3-dienoic acid. The compounds are useful as pharmaceuticals, e.g., as anti-inflammatory agents and hypolipidemic agents.
    Type: Grant
    Filed: August 15, 1975
    Date of Patent: March 8, 1977
    Assignee: Sandoz, Inc.
    Inventors: Eugene E. Galantay, Faizulla G. Kathawala
  • 9-.alpha.-methyl-steroids
    Patent number: 3997574
    Abstract: The compounds are 13-(lower)alkyl-9.alpha.-methyl-17.alpha.-propadienylgona-4-en-17.beta.-ol -3-ones and derivatives thereof, e.g. 9.alpha.-methyl-17.alpha.-propadienylestra-17.beta.-ol-3-one, and are useful as progestational agents.
    Type: Grant
    Filed: September 5, 1974
    Date of Patent: December 14, 1976
    Assignee: Sandoz, Inc.
    Inventors: Robert V. Coombs, Eugene E. Galantay
  • Substituted carbinol derivatives
    Patent number: 3997664
    Abstract: The compounds are steroidal 17-propadienyl carbinols and derivatives thereof. The compounds have estrogenic/progestational activity.
    Type: Grant
    Filed: March 24, 1975
    Date of Patent: December 14, 1976
    Assignee: Sandoz, Inc.
    Inventors: Eugene E. Galantay, Dietmar A. Habeck
  • 1-(2-Naphthyl)-2,3-butadien-1-ols
    Patent number: 3969415
    Abstract: Disclosed are compounds of the class 1-naphthyl-2,3-butadien-1-ol e.g. 2-(6'-methoxy-2-naphthyl)-3,4-pentadien-2-ol, which are useful by reason of their pharmacological activity in animals, e.g. as anti-inflammatory agents. Said compounds can be readily prepared by reduction of a corresponding 4-substituted-1-naphthyl-2-butyne-1-ol with a complex hydride such as lithium aluminium hydride.
    Type: Grant
    Filed: October 1, 1973
    Date of Patent: July 13, 1976
    Assignee: Sandoz, Inc.
    Inventor: Eugene E. Galantay
  • Substituted carbinol derivatives
    Patent number: 3961053
    Abstract: 13-alkyl-17.alpha. -propadienylgona-4,9-dien-17.beta. -ol-3-ones and their 17.beta. -oxygenated derivatives are useful in control of fertility and estrus or the menstrual cycle in warm blooded animals.
    Type: Grant
    Filed: November 18, 1974
    Date of Patent: June 1, 1976
    Assignee: Sandoz, Inc.
    Inventors: Eugene E. Galantay, Dietmar A. Habeck